Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Placebo-controlled Study of BacoMind® Bacopa Monnieri Standardized Extract in Gulf War Illness

NCT04927338 is registered in ClinicalTrials.gov with Nova Southeastern University as lead sponsor.

NCT NCT04927338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04927338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Placebo-controlled Study of BacoMind® Bacopa Monnieri Standardized Extract in Gulf War Illness
Lead sponsor
Nova Southeastern University
Phase
Phase 2
Overall status
Recruiting
Start date
December 1, 2022
Completion date
April 30, 2026
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gulf war illness